GB virus C infection and B-cell, natural killer cell, and monocyte activation markers in HIV-infected individuals

AIDS

Volumn 27, Issue 11, 2013, Pages 1829-1832

  Stapleton, Jack T ^a,b   Martinson, Jeffrey A ^c   Klinzman, Donna ^a   Xiang, Jinhua ^a,b   Desai, Seema N ^c   Landay, Alan ^c,d  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c RUSH UNIVERSITY   (United States)

^d UTRECHT UNIVERSITY   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD16 ANTIGEN; CD56 ANTIGEN; CD69 ANTIGEN; CHEMOKINE RECEPTOR CXCR4;

ARTICLE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; DISEASE COURSE; DISEASE TRANSMISSION; GB VIRUS C INFECTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE ACTIVATION; MIXED INFECTION; MONOCYTE; MORBIDITY; MORTALITY; NATURAL KILLER CELL; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS INFECTION; VIRUS LOAD;

ANTIGENS, CD56; B-LYMPHOCYTES; FLAVIVIRIDAE INFECTIONS; GB VIRUS C; GPI-LINKED PROTEINS; HEPATITIS, VIRAL, HUMAN; HIV INFECTIONS; HUMANS; IMMUNE TOLERANCE; KILLER CELLS, NATURAL; MONOCYTES; RECEPTORS, IGG;

EID: 84879853448     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e328363089f     Document Type: Article

References (10)

1. Klatt NR, Funderburg NT, Brenchley JM. Microbial translocation, immune activation, and HIV disease. Trends Microbiol 2013; 21:6-13.
2. George SL, Varmaz D, Stapleton JT. GB virus C replicates in primary T and B lymphocytes. J Infect Dis 2006; 193:451-454.
3. Zhang W, Chaloner K, Tillmann HL, Williams CF, Stapleton JT. Effect of early and late GBV-C viremia on survival of HIV infected individuals: a meta-analysis. HIV Med 2006; 7: 173-180.
4. Nattermann J, Nischalke HD, Kupfer B, Rockstroh J, Hess L, Sauerbruch T, et al. Regulation of CC chemokine receptor 5 in Hepatitis G virus infection. AIDS 2003; 17:1457-1462.
5. Maidana Giret MT, Silva TM, Sauer MM, Tomiyama H, Levi JE, Bassichetto KC, et al. GBV-C infection modulates T cell activation in recently HIV-infected subjects and is independent of HIV-1 viral load. AIDS 2009; 23:2277-2287.
6. Stapleton JT, Chaloner K, Martinson JA, Zhang J, Klinzman D, Xiang J, et al. GB virus C infection is associated with altered lymphocyte subset distribution and reduced T cell activation and proliferation in HIV-infected individuals. PLoS One 2012; 7:e50563.
7. Schwarze-Zander C, Neibecker M, Othman S, Tural C, Clotet B, Blackard JT, et al. GB virus C coinfection in advanced HIV type-1 disease is associated with low CCR5 and CXCR4 surface expression on CD4(R) T-cells. Antivir Ther 2010; 15:745-752.
8. Bhattarai N, McLinden JH, Xiang J, Kaufman TM, Stapleton JT. GB Virus C Envelope Protein E2 Inhibits TCR-Induced IL-2 Production and Alters IL-2-Signaling Pathways. J Immunol 2012; 189:2211-2216.
9. Rydze RT, Bhattarai N, Stapleton JT. GB virus C infection reduces reactivation of latent HIV and protects against T cell depletion in patients on antiretroviral therapy. Antiviral Ther 2011; 17:1271-1279.
10. Polis A, Michel T, Theresine M, Andres E, Hentges F, Zimmer J. CD56bright natural killer (NK) cells: an important NK cell subset. Immunology 2009; 126:458-465.